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Abstract: In this study, we compared 2 methods, liquid-phase blocking ELISA (LPBE) and solid-phase competition ELISA (SPCE), for
the detection of antibodies to the structural proteins of foot-and-mouth disease virus (FMDV). These methods were compared using
sera collected from cattle (n = 30) without a history of foot-and-mouth disease infection or vaccination, cattle (n = 180) vaccinated with
oil-adjuvanted bivalent vaccine, and international reference sera (positive, weak positive, and negative) for FMDV serotypes O and A.
The results showed that SPCE had a better specificity (96.67% for serotype O and 100% for serotype A) than LPBE (90% for serotype
O and 93.33% for serotype A). Sensitivity of LPBE (97.22% for serotype O and 98.33% for serotype A) was almost equivalent to that
of SPCE (98.33% for serotype O and 98.89% for serotype A). It can be concluded that SPCE is more suitable than LPBE for use as a
screening test for the detection of antibodies against structural proteins of FMDV.
Key words: Cattle, foot-and-mouth disease, structural protein, liquid-phase blocking ELISA, solid-phase competition ELISA

1. Introduction
Foot-and-mouth disease (FMD) is a highly contagious
viral disease of cloven-hoofed animals that causes
international trade restrictions in livestock and their
products. Major clinical features of the disease are fever;
lameness; vesicles in the mouth, feet, and teats; and high
morbidity. Young animals have higher mortality than
adults because of myocarditis (1). It has been eradicated
from North America and Europe but continues to exist in
parts of South America, Africa, the Middle East, Asia, and
the Anatolian region of Turkey (2).
The etiological agent, FMD virus (FMDV), is a member
of the genus Aphthovirus in the family Picornaviridae,
and it has 7 different serotypes: O, Asia 1, A, C, and
South African territories 1 (SAT 1), SAT 2, and SAT 3
(1,3). The genome encodes 4 structural proteins, VP1
to VP4 (4). The G-H loop of VP1 has been identified as
the major antigenic site (5). The genome also codes for 8
nonstructural proteins (Lpro, 2A, 2B, 2C, 3A, 3B, 3Cpro, and
3D-RNA–dependent RNA polymerase) (1).
FMDV has very high mutation rates because of the
lack of a proofreading mechanism of the viral RNAdependent RNA polymerase (6). The antigenic variants are
caused by mutations leading to difficulties in the control
* Correspondence: dr_muratank@hotmail.com

of FMD (1). Vaccination is an effective tool for controlling
the disease. Inactivated viral strains of FMDV are used
as a vaccine (7). Using oil-adjuvanted vaccines has been
shown to induce higher levels of antibody than aluminum
hydroxide gel-saponin adjuvanted vaccines (8).
Protection against FMD following vaccination is
related with the serum neutralizing antibody levels (9). It
has been reported that FMD-specific IgM can be detected
2 to 4 days after vaccination (10). Immunity level of the
vaccinated cattle population is readily measured by
detecting antibodies to the capsid or structural proteins
of the virus (11). The internationally accepted tests for
determining the FMD antibody status of livestock are the
virus neutralization test (VNT), liquid-phase blocking
ELISA (LPBE), and solid-phase competition ELISA
(SPCE) (12). The VNT is considered to be sensitive,
specific and reliable; however, it takes several days (13).
ELISA-based methods offer many advantages including
high sensitivity, suitability for large-scale screening of field
samples, and lack of a requirement for special laboratory
conditions, e.g., cell culture or CO2 environment (13,14).
Therefore, these methods have been used to measure
antibody levels of vaccinated animals. The aim of this
study was to compare the diagnostic value of these ELISA
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methods for the detection of antibodies to the structural
proteins of FMDV serotypes O and A.
2. Materials and methods
2.1. Positive sera
A total of 180 cattle (100 Brown Swiss hybrid, 60 Jersey
hybrid, and 20 Holstein Friesian hybrid) that had no record
of FMD for many years were used for the study. Cattle
were vaccinated with oil-adjuvanted bivalent vaccine
(containing O1 Manisa and A22 Iraq FMDV strains; payload
of antigens of 6 µg and 4 µg, respectively) formulated in
a double oil emulsion adjuvant. The same batches of a
commercial vaccine were used. Vaccination was carried
out by injection of 2-mL volumes subcutaneously. Serum
samples were collected 28 days after vaccination. This
study was approved by the ethics board of the Faculty of
Veterinary Medicine, Selçuk University, Konya, Turkey
(Approval No. 2008/081).
2.2. Negative sera
Sera from cattle (n = 30) with no history of infection or
vaccination with FMDV were supplied by Institute for
Foot and Mouth Disease, Turkey.
2.3. Test reagents
International reference sera (strong positive antiserum,
weak positive antiserum, and negative serum) for FMDV
serotype O and serotype A, rabbit anti-FMDV sera
(trapping), and guinea pig (detector) antiserum were
obtained from the Institute for Animal Health, Pirbright
Laboratory, UK. Antigens of the serotype O and serotype A
and horseradish peroxidase conjugated rabbit anti-guinea
pig immunoglobulin were obtained from the Institute for
Foot and Mouth Disease, Turkey.
2.4. Liquid-phase blocking ELISA
The principle of the LPBE assay is liquid-phase blocking
of FMDV antigen by specific antibodies in the sera. The
LPBE was performed according to the method of Hamblin
et al. (14). Briefly, ELISA plates were coated with serotypespecific (serotypes O and A) rabbit anti-FMDV serum
and held overnight at 4 °C. In carrier plates, 2-fold series
of each test serum were prepared, from 1/16 to 1/128.
Control sera (strong and weak positive, and negative) were
diluted at 1/16. To each well, addition of the viral antigen
increased the final serum dilution to 1/32. The plates
were left overnight at 4 °C. Afterwards, rabbit antiserumcoated ELISA plates were washed 3 times with phosphatebuffered saline containing 0.05% Tween 20 (PBST) (pH
7.4), and serum/antigen mixtures were transferred from
the carrier plates to the rabbit-serum–coated ELISA plates.
Homologous guinea pig antiserum was then added to each
well and incubated at 37 °C for 1 h. After incubation,
rabbit anti-guinea pig immunoglobulin conjugated to
horseradish peroxidase was added to each well. The plates
were washed after 1 h of incubation and substrate solution
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(orthophenylene diamine [OPD] + 0.05% H2O2) was
added to each well. After 15 min of incubation at room
temperature, the reaction was stopped by adding 1.25 M
sulfuric acid. The optical density (OD) of each well was read
at 492 nm using a spectrophotometer (Molecular Devices,
Sunnyvale, CA, USA), and percentage of inhibition (PI)
values were calculated. The sera were considered positive
at PI ≥ 50% (14).
2.5. Solid-phase competition ELISA
The SPCE assay is based on competition between
antibodies in serum and guinea pig anti-FMDV antiserum
for binding to FMDV antigen. The SPCE was carried out
as described by Mackay et al. (13). Plates were coated with
serotype-specific (serotypes O and A) rabbit anti-FMDV
antiserum and incubated at 4 °C for 24 h. FMDV antigen
was added to each well of the ELISA plates and the plates
were incubated at 37 °C for 1 h. After washing, test sera and
control sera (2-fold dilutions of an initial serum dilution of
1:2.5 through 1:20), in blocking buffer (PBST containing
10% normal bovine serum and 5% normal rabbit serum),
were added and immediately the addition of serotypespecific guinea pig antiserum immediately followed, giving
a final serum dilution of 1/5. Plates were incubated at 37
°C for 1 h. Anti-guinea pig immunoglobulin conjugated
with horseradish peroxidase was added to all wells and the
plates were incubated at 37 °C for 1 h. After the washing
step, substrate/chromogen (OPD + 0.05% H2O2) was
added to each well. Finally, the reaction was stopped after
15 min by adding 1.25 M sulfuric acid, and OD values at
492 nm were read using a spectrophotometer (Molecular
Devices). Sera giving PI values equal to or greater than
60% were considered positive (15).
3. Results
3.1. The specificity and sensitivity of LPBE
The sensitivity and specificity were calculated using
standard methods (16,17). Sensitivity was calculated
as true positive / true positive + false negative whereas
specificity was true negative / true negative + false
positive; the results of both calculations were expressed as
percentages (16) (Tables 1 and 2).
The specificity of LPBE was evaluated with sera
collected from cattle that had never been infected or
vaccinated with FMDV. A total of 30 sera were tested
for antibodies to serotype O, and 3 out of 30 sera (90%)
gave positive results. In contrast, specificity of the LPBE
for serotype A was 93.33% (2/30) when testing the same
negative sera (Table 1). Thus, the specificity of LPBE was
over 90%.
The sensitivity of LPBE was estimated using positive
sera (n = 180) that had originated from vaccinated cattle.
Serotype O antibody was detected in 175 (97.22%) and
serotype A antibody in 177 (98.33%) of 180 sera (Table 2).
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Table 1. Specificities of LPBE and SPCE.
FMDV
O1 Manisa
A22 Iraq

Test

No. of sera examined

No. of negative sera

Specificity (%)

95% confidence interval

LPBE

30

27

90.0

73.44%–97.77%

SPCE

30

29

96.67

82.72%–99.44%

LPBE

30

28

93.33

77.89%–98.99%

SPCE

30

30

100.0

88.32%–100.0%

Table 2. Sensitivities of the LPBE and SPCE methods.
FMDV
O1 Manisa
A22 Iraq

Test

No. of sera examined

No. of positive sera

Sensitivity (%)

95% confidence interval

LPBE

180

175

97.22

93.63%–99.08%

SPCE

180

177

98.33

95.20%–99.64%

LPBE

180

177

98.33

95.20%–99.64%

SPCE

180

178

98.89

96.04%–99.83%

3.2. The specificity and sensitivity of SPCE
The specificity and sensitivity of SPCE was evaluated using
the same sera. Of the 30 negative sera tested by SPCE, 1
was considered positive against serotype O (96.67%) and
all negative sera had less than 60% inhibition against
serotype A (100%). The specificity of SPCE was over 96%
(Table 1).
The sensitivity of SPCE was estimated using positive
samples of sera (n = 180). When testing by SPCE, 177
(98.33%) of the 180 sera were positive for serotype O and
178 (98.89%) sera were positive for serotype A (Table 2).
3.3. Examination of reference sera
Reference sera were examined by LPBE and SPCE
for screening assays. In LPBE, the strong positive (PI:
86%–95%) and weak positive (PI: 55%–72%) reference

sera were found to be positive. The negative results were
0%–30% PI. In SPCE, reference sera produced results
within the expected range for the negative (PI: 0%–30%),
weak positive (PI: 56%–75%), and strong positive (PI:
83%–96%) samples. LPBE and SPCE scored all negative
references as negative (Table 3).
3.4. Repeatability of the assays
Repeatability of LPBE and SPCE was assessed based
on the results of the strong positive, weak positive, and
negative control sera tested on the same day (within-run
repeatability) and on different days over the study period
(between-run repeatability). Reference sera showed very
consistent results when tested by LPBE and SPCE. PIs
for all negative controls were below the cut-off for each
serotype (cut-off of 50% PI and 60% PI for LPBE and

Table 3. Results of the international reference sera tested by LPBE and SPCE.
Reference sera
O1 Manisa

A22 Iraq

LPBE % inhibitiona

SPCE % inhibition

Strong positive

91 ± 2.2

91 ± 2.6

Weak positive

58 ± 2.6

61 ± 4.4

Negative

7 ± 6.2

13 ± 10.8

Strong positive

89 ± 2.3

86 ± 3.2

Weak positive

63 ± 4.5

64 ± 5.8

Negative

9 ± 6.6

12 ± 7.6

: Values are expressed as the mean percentage inhibition of the sera ± standard deviation.

a
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SPCE, respectively). The variation for all positive and
negative controls for each serotype was not significant
as the PI obtained for controls was within 2 standard
deviations with coefficients of variation of less than 20%
(16) (Table 4).
4. Discussion
FMD is endemic in the Anatolian region of Turkey;
however, the Thrace region has not had a FMD case
since 2001. Most outbreak-associated FMDV serotypes
are serotype O or serotype A. Outbreak due to serotype
Asia 1 was also reported in 2011. Genetic analysis of
FMD viruses demonstrated that the Turkish isolates are
closely related to the Middle East isolates. In Turkey,
control strategies for FMD are based on vaccination,
quarantine, and control of animal movements (2,18,19,20).
Postvaccination serosurveillance is an important indicator
for the evaluation of preventive vaccination programs.
Inactivated FMD vaccines are used in most parts of the
world (21). Cattle vaccinated with inactivated vaccines
produce antibodies only to the structural proteins (22).
The internationally accepted methods for the
determination of antibody response after vaccination
are the VNT, LPBE, and SPCE. The reference method
for the detection of antibodies against structural proteins
of the FMDV is the VNT; however, it takes 2–3 days to
complete, requires cell culture and live virus, and must
be performed in high-security conditions. These special
requirements of the VNT make it not suitable for largescale serological surveillance. Therefore, LPBE has been
applied as a routine screening method for FMDV in
many laboratories. It is easier to perform and its results

are consistent with those of the VNT (12,14). However,
it has several drawbacks, including lack of stability of
inactivated antigens and false positive reactions occurring
at a rate of 4% up to 18% (22,23). For these reasons,
SPCE has been developed for the detection of antibodies
against FMDV. One of the advantages of SPCE is its
highly purified and adequately stable 146S preparations
of virus used as antigen (13).
The aim of this study was to determine diagnostic
values of LPBE and SPCE. Using the same set of cattle
sera, we compared LPBE and SPCE for their specificity
and sensitivity. We determined that specificities of LPBE
for serotype O and serotype A were lower than those
achieved with SPCE (Table 1). Serotype O and A LPBE
gave a specificity of 90% and 93.33%, respectively, at a cutoff of 50 PI (14). A cut-off value of 60 PI (15) was used for
serotypes O and A SPCE, which gave a specificity of 96.67%
and 100%, respectively. Mackay et al. (13) and Niedbalski
(24) also obtained similar results, and they reported that
specificity of SPCE was considerably higher than that of
LPBE. In another study, Paiba et al. (15) reported that
specificity of SPCE for serotype O at a cut-off point of 60
PI was 99.44% for cattle sera, 99.50% for sheep sera, and
100% for pig sera.
The sensitivity of SPCE determined by testing positive
sera was slightly higher than that of LPBE (Table 2). Similar
results were obtained in other studies (13,25,26). Martinez
and Quintero (27) reported that sensitivity of LPBE for
serotype O1 Cruzeiro was 96%. Brocchi et al. (25) found
that diagnostic sensitivity of SPEC was 99.7%. Niedbalski
(24) reported that sensitivity of LPBE and SPCE was 99.1%
and 99.4%, respectively.

Table 4. Repeatability data for strong and weak positives and negative reference sera.
Within-run
Test

LPBE

C-

b

b
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C+

C-

A22

O1

A22

O1

A22

O1

A22

O1

A22

O1

A22

89.3d

86.0

57.6

57.5

0.6g

0.4

92.7

89.2

57.7

59.9

0.9

0.6

1.2

2.2

2.8

4.0

0.07

0.05

1.6

3.1

2.5

2.3

0.1

0.08

2.5%

4.9%

7.0%

12.5%

12.0%

1.7%

3.5%

4.4%

3.9%

16%

13.2%

92.4

88.6

62.0

64.2

1.2

1.06

89.7

84

60.1

62.0

0.9

1.05

3.3

2.7

3.7

5.6

0.1

0.2

1.6

1.9

5.1

4.7

0.2

0.1

3.5%

3.1%

5.9%

8.8%

12.3%

18.5%

1.7%

2.3%

8.5%

7.7%

24.2%

16.2%

e
f

: Strong positive control serum.
: Weak positive control serum.
c
: Negative control serum.
d
: Results are expressed as the percentage inhibition.
a

C ++

c

O1

1.3%
SPCE

Between-run
C+

C ++

a

: Standard deviation.
: Coefficient of variation.
g
: Optical density of the negative control serum.
e

f
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Log 2 titer

International reference sera were tested by LPBE
and SPCE methods and the results were compared. All
strong and weak positive reference sera were detected
as positive by the LPBE and SPCE methods (Table 3).
The repeatability of LPBE and SPCE were assessed by
calculating the coefficients of variation (Table 4). The
coefficients of variation calculated were less than 10%
for reference sera, considered acceptable for practical
use (16). Additionally, PIs obtained were consistently
within the range of 2 standard deviations, which means
that the variation between tests was within the normal
range of acceptability. Weak positive sera showed very
consistent results when tested using LPBE and SPCE.
It has been suggested that weak positive reference serum
is the minimum standard for the serologic assays used for
herd-based serosurveillance (24). Therefore, these data
suggest that LPBE and SPCE can be useful to assess of the
herd immunity levels induced by vaccination.
The possibility of using LPBE and SPCE to measure
an antibody response was also investigated by testing 180
sera from vaccinated cattle. The results demonstrated that
SPCE antibody titers for FMDV serotypes O and A were all
9
8.5
8
7.5
7
6.5
6
5.5
5
4.5
4
3.5
3
2.5
2
1.5
1
0.5
0

(A)

similar to or higher than LPBE antibody titers. The highest
titers obtained by SPCE for samples of serotypes O and A
were more than 2 times higher than those measured by
LPBE (Figure). These results suggested that the SPCE can
detect lower amounts of FMDV serotype O- and serotype
A-specific antibodies than the LPBE.
In conclusion, this study has demonstrated that SPCE
for FMDV serotypes O and A as both a screening and
a titration assay was sensitive and specific. Additional
advantages of SPCE are that the assay is easier to perform
and is carried out with inactivated virus antigen, unlike the
VNT. SPCE is more suitable than LPBE for the evaluation
of vaccination programs as well as import/export testing
in support of international trade, because of its high
specificity and sensitivity and its low variation in results.
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Figure. Comparison of antibody titers in animals vaccinated (n = 25) with types O1 Manisa and A22 Iraq as measured by LPBE and
SPCE. A: O1 Manisa, B: A22 Iraq.
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